Group One Trading
ROSG

Group One Trading’s Rosetta Genomics Ltd. ROSG Stock Holding History

Group One Trading’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-75
Closed -$956 – 5334
2015
Q4 		$1K Sell
75
-800
-91% -$17.3K ﹤0.01% 4658
2015
Q3 		$26K Buy
875
+92
+12% +$3.14K ﹤0.01% 3917
2015
Q2 		$32K Buy
783
+239
+44% +$10.2K ﹤0.01% 3808
2015
Q1 		$20K Buy
544
+268
+97% +$10.2K ﹤0.01% 3892
2014
Q4 		$7K Buy
+276
New +$8.96K ﹤0.01% 4376
2014
Q1 		– Sell
-444
Closed -$22.9K – 5853
2013
Q4 		$16K Sell
444
-334
-43% -$11.6K ﹤0.01% 4386
2013
Q3 		$30K Sell
778
-250
-24% -$10.1K ﹤0.01% 3919
2013
Q2 		$42K Buy
+1,028
New +$45.7K ﹤0.01% 3578

Other funds holding ROSG

HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Group One Trading's ROSG Position: Q1 2016 in Review

Group One Trading sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2016, closing a stake of 75 shares — an estimated $956 sold.

Group One Trading first reported a position in ROSG in Q2 2013 and held it in 8 quarters. The position peaked at $42K in Q2 2013. 10 funds tracked by Wall St. Rank hold ROSG as of Q1 2016.

  • Group One Trading reported no remaining Rosetta Genomics Ltd. position as of Q1 2016 after selling out during the quarter.
  • Group One Trading sold 75 Rosetta Genomics Ltd. shares in Q1 2016, an estimated $956.
  • Group One Trading first reported a position in Rosetta Genomics Ltd. in Q2 2013 and held it in 8 quarters.
  • Group One Trading's Rosetta Genomics Ltd. position peaked at $42K in Q2 2013.
  • 10 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2016.

Based on Group One Trading's 13F filing for Q1 2016, filed 12 May 2016.